目前关于铁死在瘤免疫逃避中的作用的进展
Changlin Gao1, Haoran Zhang2,3, Xianwei Wang4
1Graduate School of Hebei Medical University, Shijiazhuang, 050017, Hebei, China.
Discover oncology
|December 2, 2024
概括
铁,一种涉及铁的细胞死亡形式,通过影响瘤免疫逃避,影响癌症免疫疗法. 了解铁亡是改善免疫检查点抑制剂等治疗方法的关键.
科学领域:
- 在瘤学瘤学.
- 细胞死亡研究 细胞死亡研究
- 免疫治疗是一种免疫疗法.
背景情况:
- 铁亡是一种受调节的细胞死亡,标志着铁的积累和脂质过氧化.
- 癌症免疫疗法,包括免疫检查点抑制剂 (ICI),显示出希望,但面临着瘤免疫逃避的挑战.
- 瘤微环境 (TME) 因素,包括铁,在免疫疗法失败中至关重要.
研究的目的:
- 审查癌症中铁亡的最新进展.
- 探索铁灭菌在瘤免疫逃避中的作用及其与TME的相互作用.
- 总结癌症免疫疗法的铁灭诱导和抑制策略.
主要方法:
- 关于癌症中的铁灭机制的文献综述.
- 分析铁灭与瘤微环境的相互作用.
- 综合关于基于铁灭的癌症治疗策略的当前研究.
主要成果:
- 铁酶在瘤免疫逃避中起着复杂的作用,影响免疫治疗的疗效.
- 铁和TME之间的相互作用对于理解治疗反应至关重要.
- 铁灭的诱导和抑制都显示出在癌症中潜在的治疗应用.
结论:
- 铁化是癌症治疗中的双刃剑,对免疫疗法有重大影响.
- 需要进一步的研究来克服挑战,并优化基于铁灭的疗法.
- 向铁灭症为增强癌症免疫疗法和治疗提供了有希望的未来方向.
更多相关视频
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
5.5K
09:21Ferritinophagy: Assessing the Selective Degradation of Iron by Autophagy in Human Fibroblasts
Published on: February 23, 2024
829
相关概念视频
01:16Necrosis
4.3K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.3K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:27Tumor Immunotherapy
476
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
476
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K